▼
Showing posts with label Johnson and Johnson. Show all posts
Showing posts with label Johnson and Johnson. Show all posts
Wednesday, 10 December 2025

Johnson & Johnson: has a secure growing income stream and ability to deploy massive capital for high-return growth

›
Here is a comprehensive summary of Johnson & Johnson's financial statements and an overall assessment. 1. Income Statement Summary: ...
Sunday, 14 April 2024

Johnson & Johnson

›
  Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow Apr. 12, 2024 Summary Johnson & Johnson (JNJ) is positioned t...
Saturday, 13 April 2024

Unlocking Q1 Potential of Johnson & Johnson (JNJ)

›
Unlocking Q1 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics Zacks Equity Research Thu, 11 April 2...
Tuesday, 5 March 2024

Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 41% Undervaluation?

›
Comment:    An example of using 2 stage growth model and discount cash flow method in valuing a company. The discount cash flow method is ba...
Friday, 29 September 2023

JOHNSON & JOHNSON

›
  Revenues increased from US 71.3 B in 2013 to US 94.9 B in 2022. PBT increased from  US15.5 B in 2013 to US 21,7 B in 2022. EPS increased f...
Monday, 25 September 2023

Johnson and Johnson

›
 
Wednesday, 16 December 2015

Johnson & Johnson

›
Johnson & Johnson JNJ (NYSE) Website:  www.jnj.com Sector:  Health Care Beta Coefficient: 0.5 10 Yr Compound EPS Growth: ...
Saturday, 7 July 2012

5 Companies You Can Buy Today

›
By Morgan Housel July 6, 2012 There are many ways to value a company. Price to earnings. Price to cash flow. Liquidation value. Price p...